FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mathilde Hunault-Berger

Research Profile

Concepts & Ideas

Procedures

Chemicals & Drugs

Disorders

Co-author Network

Publications

TOP 3
Diane Raingeard de la Blétière; Yves Delneste; Frank Geneviève; Laurence Baranger; Annaelle Beucher; Odile Blanchet; Pascale Cornillet-Lefèbvre; Anne Coutolleau; Mathilde Hunault-Berger; Norbert Ifrah; Isabelle Luquet; Aline Schmidt-Tanguy; Marc Zandecki; Philippe Guardiola
Routine use of microarray-based gene expression profiling to identify patients with low cytogenetic risk acute myeloid leukemia: accurate results can be obtained even with suboptimal samples.
Mathilde Hunault-Berger; Thibaut Leguay; Xavier Thomas; Ollivier Legrand; Françoise Huguet; Caroline Bonmati; Martine Escoffre-Barbe; Laurence Legros; Pascal Turlure; Patrice Chevallier; Fabrice Larosa; Frederic Garban; Oumedaly Reman; Philippe Rousselot; Nathalie Dhédin; André Delannoy; Marina Lafage-Pochitaloff; Marie Christine Béné; Norbert Ifrah; Hervé Dombret
A randomized study of pegylated liposomal doxorubicin versus continuous-infusion doxorubicin in elderly patients with acute lymphoblastic leukemia: the GRAALL-SA1 study.
Marie-Pierre Moles-Moreau; Catherine Ternisien; Aline Tanguy-Schmidt; Françoise Boyer; Martine Gardembas; Mamoun Dib; Anne Ponthieux; Philippe Guardiola; Norbert Ifrah; Mathilde Hunault-Berger
Flow cytometry-evaluated platelet CD36 expression, reticulated platelets and platelet microparticles in essential thrombocythaemia and secondary thrombocytosis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mathilde Hunault-Berger (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Diane Raingeard de la Blétière; Yves Delneste; Frank Geneviève; Laurence Baranger; Annaelle Beucher; Odile Blanchet; Pascale Cornillet-Lefèbvre; Anne Coutolleau; Mathilde Hunault-Berger; Norbert Ifrah; Isabelle Luquet; Aline Schmidt-Tanguy; Marc Zandecki; Philippe Guardiola
Routine use of microarray-based gene expression profiling to identify patients with low cytogenetic risk acute myeloid leukemia: accurate results can be obtained even with suboptimal samples.
BMC medical genomics 2012;5():6.
2011: Mathilde Hunault-Berger; Thibaut Leguay; Xavier Thomas; Ollivier Legrand; Françoise Huguet; Caroline Bonmati; Martine Escoffre-Barbe; Laurence Legros; Pascal Turlure; Patrice Chevallier; Fabrice Larosa; Frederic Garban; Oumedaly Reman; Philippe Rousselot; Nathalie Dhédin; André Delannoy; Marina Lafage-Pochitaloff; Marie Christine Béné; Norbert Ifrah; Hervé Dombret
A randomized study of pegylated liposomal doxorubicin versus continuous-infusion doxorubicin in elderly patients with acute lymphoblastic leukemia: the GRAALL-SA1 study.
Haematologica 2011;96(2):245-52.
2010: Marie-Pierre Moles-Moreau; Catherine Ternisien; Aline Tanguy-Schmidt; Françoise Boyer; Martine Gardembas; Mamoun Dib; Anne Ponthieux; Philippe Guardiola; Norbert Ifrah; Mathilde Hunault-Berger
Flow cytometry-evaluated platelet CD36 expression, reticulated platelets and platelet microparticles in essential thrombocythaemia and secondary thrombocytosis.
Thrombosis research 2010;126(5):e394-6.
2010: Arnaud Pigneux; Jean-Luc Harousseau; Francis Witz; Mathieu Sauvezie; Marie-Christine Bene; Isabelle Luquet; Mathilde Hunault-Berger; Christian Recher; Bruno Lioure; Chantal Himberlin; Martine Escoffre-Barbe; Christian Berthou; Severine Lissandre; Nathalie Fegueux; Jean-Yves Cahn; Eric Jourdan; François Dreyfus; Josy Reiffers; Noël Milpied; Norbert Ifrah
Addition of lomustine to idarubicin and cytarabine improves the outcome of elderly patients with de novo acute myeloid leukemia: a report from the GOELAMS.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(18):3028-34.
2009: Olivier Kosmider; Véronique Gelsi-Boyer; Meyling Cheok; Sophie Grabar; Véronique Della Valle; Françoise Picard; Franck Viguié; Bruno Quesnel; Odile Beyne-Rauzy; Eric Solary; Norbert Vey; Mathilde Hunault-Berger; Pierre Fenaux; Véronique Mansat-De Mas; Eric Delabesse; Philippe Guardiola; Catherine Lacombe; William Vainchenker; Claude Preudhomme; François Dreyfus; Olivier A Bernard; Daniel Birnbaum; Michaëla Fontenay
TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs).
Blood 2009;114(15):3285-91.
2009: Patrice Chevallier; Mathilde Hunault-Berger; Fabrice Larosa; Charles Dauriac; Richard Garand; Jean-Luc Harousseau
A phase II trial of high-dose imatinib mesylate for relapsed or refractory c-kit positive and Bcr-Abl negative acute myeloid leukaemia: the AFR-15 trial.
Leukemia research 2009;33(8):1124-6.
2008: Mathilde Hunault-Berger; Patrice Chevallier; Martine Delain; Claude-Eric Bulabois; Serge Bologna; Marc Bernard; Ingrid Lafon; Jérome Cornillon; Abdallah Maakaroun; Alexandra Tizon; Bruno Padrazzi; Norbert Ifrah; Yves Gruel
Changes in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: the CAPELAL study.
Haematologica 2008;93(10):1488-94.
2008: Benjamin Terrier; Arnaud Jaccard; Jean-Luc Harousseau; Richard Delarue; Olivier Tournilhac; Mathilde Hunault-Berger; Mohamed Hamidou; Jacques Dantal; Marc Bernard; Bernard Grosbois; Pierre Morel; Valérie Coiteux; Olivier Gisserot; Philippe Rodon; Arnaud Hot; Caroline Elie; Véronique Leblond; Jean-Paul Fermand; Fadi Fakhouri
The clinical spectrum of IgM-related amyloidosis: a French nationwide retrospective study of 72 patients.
Medicine 2008;87(2):99-109.
2007: M-P Moles; Maud Brousseau; A-P Rachieru; Alban Godon; A Schmidt; A Furber; Marie-Christine Rousselet; Mathilde Hunault-Berger
[Tumor like presentation of primitive amyloidosis: amyloidoma].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 2007;28(5):339-42.
2005: Pierre Sujobert; Valérie Bardet; Pascale Cornillet-Lefebvre; Joel S Hayflick; Nolwen Prie; Frédérique Verdier; Bart Vanhaesebroeck; Odile Muller; Florence Pesce; Norbert Ifrah; Mathilde Hunault-Berger; Christian Berthou; Bruno Villemagne; Eric Jourdan; Bruno Audhuy; Eric Solary; Brigitte Witz; Jean-Luc Harousseau; Chantal Himberlin; Thierry Lamy; Bruno Lioure; Jean-Yves Cahn; François Dreyfus; Patrick Mayeux; Catherine Lacombe; Didier Bouscary
Essential role for the p110delta isoform in phosphoinositide 3-kinase activation and cell proliferation in acute myeloid leukemia.
Blood 2005;106(3):1063-6.
2005: Mathilde Hunault-Berger; A Tanguy-Schmidt; Petronela Rachieru; Vincent Lévy; Malgorzata Truchan-Graczyk; S Francois; M Gardembas-Pain; M Dib; Charles Foussard; N Piard; Alban Godon; Philippe Solal-Celigny; Norbert Ifrah
rHuEpo before high-dose therapy allows autologous peripheral stem-cell transplantation without red blood cell transfusion: a pilot study.
Bone marrow transplantation 2005;35(9):903-7.
2003: Eric Solary; Bernard Drenou; Lydia Campos; Patricia de Crémoux; Francine Mugneret; Philippe Moreau; Bruno Lioure; Annie Falkenrodt; Brigitte Witz; Marc Bernard; Mathilde Hunault-Berger; Martine Delain; José Fernandes; Christiane Mounier; françois guilhot; Francine Garnache; Christian Berthou; Fawzi Kara-Slimane; Jean-Luc Harousseau
Quinine as a multidrug resistance inhibitor: a phase 3 multicentric randomized study in adult de novo acute myelogenous leukemia.
Blood 2003;102(4):1202-10.
2002: Mathilde Hunault-Berger; Norbert Ifrah; Philippe Solal-Celigny
Intensive therapies in follicular non-Hodgkin lymphomas.
Blood 2002;100(4):1141-52.
2001: Mathilde Hunault-Berger; Noël Milpied; Marc Bernard; Jean-Pierre Jouet; Martine Delain; Bernard Desablens; Alain Sadoun; françois guilhot; Philippe Casassus; Norbert Ifrah
Daunorubicin continuous infusion induces more toxicity than bolus infusion in acute lymphoblastic leukemia induction regimen: a randomized study.
Leukemia 2001;15(6):898-902.
2001: Mathilde Hunault-Berger; Petronela Rachieru; C Ternisien; Henri Jardel; Marc Zandecki; M Boasson; Norbert Ifrah
[Acquired von Willebrand disease and lymphoproliferative syndromes].
Presse médicale (Paris, France : 1983) 2001;30(5):209-12.
2001: G Berger; Mathilde Hunault-Berger; Petronela Rachieru; M Fontenay-Roupie; Laurence Baranger; Norbert Ifrah; Marc Zandecki
Increased apoptosis in mononucleated cells but not in CD34+ cells in blastic forms of myelodysplastic syndromes.
The hematology journal : the official journal of the European Haematology Association / EHA 2001;2(2):87-96.
2000: Jean-Luc Harousseau; Brigitte Witz; Bruno Lioure; Mathilde Hunault-Berger; Bernard Desablens; Martine Delain; françois guilhot; P Y Le Prise; Jean-François Abgrall; Eric DECONINCK; Denis Guyotat; Jean-Pierre Vilque; Philippe Casassus; Olivier Tournilhac; Bruno Audhuy; Eric Solary
Granulocyte colony-stimulating factor after intensive consolidation chemotherapy in acute myeloid leukemia: results of a randomized trial of the Groupe Ouest-Est Leucémies Aigues Myeloblastiques.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(4):780-7.
1999: Mathilde Hunault-Berger; Isabelle Pellier; Norbert Ifrah
[Acute lymphoblastic leukemias (adult and child)].
La Revue du praticien 1999;49(4):441-5.